A study by Hermansen et al. compared treatment with insulin analogs (insulin detemir/insulin aspart) to human insulins (NPH insulin/regular human insulin) in people with type 1 diabetes without increased risk of hypoglycemia (Hermansen et al., 2004). This evidence concerns the gene INS and type 1 diabetes mellitus.